Skip to content

Member

Cecilia STRADA

S&D · Italy

Group
S&D
Country
Italy
Roll-call participation
92.6 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
93.6 %ⓘ of 574 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
PD Partito Democratico
In office
Since 16 Jul 2024
Against clear line
34 of 567 votesⓘ
Committees
DEVE (substitute), EMPL (substitute), FEMM (substitute), LIBE
Member id
257101
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

92.6 %

574 of 620 final votes while in office

S&D median: 89.5 % (+3.1 pts)

Chamber median: 90.6 %

With majority line ⓘ

93.6 %

537 of 574 votes where their group had a line

S&D median: 97.1 % (−3.6 pts)

Against clear line ⓘ

6.0 %

34 of 567 votes where their group had a clear line

13 opposite (for ↔ against), 20 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

4.0 %

23 of 574 votes cast

Participation 92.6 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Cecilia STRADA92.6 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 93.6 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Cecilia STRADA93.6 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: For Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: For Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: Against Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 6 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Marco TARQUINIO S&DItaly96 % of 4 757 shared93 %
Annalisa CORRADO S&DItaly95 % of 4 503 shared93 %
Sandro RUOTOLO S&DItaly94 % of 4 097 shared93 %
Alessandra MORETTI S&DItaly94 % of 5 162 shared93 %
Irene TINAGLI S&DItaly94 % of 5 312 shared93 %
Matteo RICCI S&DItaly94 % of 4 459 shared93 %
Brando BENIFEI S&DItaly94 % of 4 294 shared93 %
Antonio DECARO Former memberS&DItaly93 % of 2 089 shared93 %
Giuseppe LUPO S&DItaly93 % of 5 115 shared93 %
Nicola ZINGARETTI S&DItaly93 % of 4 867 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Irena JOVEVA RenewSlovenia86 % of 5 231 shared86 %
Barry ANDREWS RenewIreland85 % of 4 819 shared86 %
Elisabetta GUALMINI changed group RenewItaly85 % of 1 733 shared86 %
Billy KELLEHER RenewIreland85 % of 5 252 shared86 %
Vladimir PREBILIČ GreensSlovenia85 % of 4 718 shared83 %
Mélissa CAMARA GreensFrance85 % of 4 702 shared83 %
Barry COWEN RenewIreland85 % of 4 774 shared86 %
Jana TOOM RenewEstonia84 % of 4 695 shared86 %
Gerben-Jan GERBRANDY RenewNetherlands84 % of 5 417 shared86 %
Benedetta SCUDERI GreensItaly84 % of 5 233 shared83 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on DevelopmentDEVE CommitteeSubstitute19 Jul 2024now
Committee on Employment and Social AffairsEMPL CommitteeSubstitute19 Jul 2024now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute19 Jul 2024now
Committee on Civil Liberties, Justice and Home AffairsLIBE CommitteeMember19 Jul 2024now
Delegation for relations with the Mashreq countriesDMAS DelegationVice-chair3 Oct 2024now
Delegation for relations with PalestineDPAL DelegationSubstitute19 Sept 2024now
Intergroup on Anti-Racism and DiversityIG10-02 Intergroup / working groupMember13 Nov 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember24 Jan 2025now

Show all 14 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationLIBE2 Sept 2026
Situation of international law and the risks to multilateralism, democracy and the European UnionOpinion rapporteurDEVE31 Aug 2026
Recommendation to the Council, the Commission and the Vice-President of the Commission / High Representative of the Union on Foreign Affairs and Security Policy on promoting transnational governance on water in the interests of conflict prevention and peaceShadow rapporteur for an opinionDEVE2 Dec 2025
Amending Regulation (EU) 2024/1348 as regards the establishment of a list of safe countries of origin at Union levelShadow rapporteurLIBE22 Jul 2025
Amending Regulation (EU) 2024/1348 as regards the application of the ‘safe third country’ conceptShadow rapporteurLIBE22 Jul 2025
Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crisesShadow rapporteur for an opinionFEMM25 Jun 2025
Gender inequalities in health, specifically as regards gender-specific conditionsShadow rapporteurFEMM23 Jun 2025
No dossier namedOfficial delegationLIBE30 Apr 2025
No dossier namedOfficial delegationLIBE9 Apr 2025
No dossier namedShadow rapporteurLIBE13 Nov 2024

Show all 11 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

47 contributions recorded; 4 on behalf of their group; 57 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 132

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
15 Sept 2026Common security and defence policy mission to Lebanon E-10-2026-003673Written questionwith 11 co-authorsNot yet answered
15 Sept 2026REPowerEU-funded redevelopment of public housing in Milan’s Lulli-Porpora district E-10-2026-003666Written questionwith 5 co-authorsNot yet answered
7 Sept 2026Extraterritorial impact of the US designation of Autistici/Inventati as a terrorist entity P-10-2026-003526Priority written questionwith 28 co-authorsNot yet answered
22 Jul 2026Cutro shipwreck, tragedies at sea and the right of vicitms’ families E-10-2026-003097Written questionwith 23 co-authors22 Sept 2026
16 Jul 2026Humanitarian situation of Sahrawi refugees, inadequate EU humanitarian assistance and the growing water crisis in the refugee camps E-10-2026-003027Written questionwith 22 co-authors27 Aug 2026
16 Jul 2026Urgent appeal for the release of Dr Hussam Abu Safiya E-10-2026-003029Written questionwith 17 co-authors2 Sept 2026
15 Jul 2026Implementation of Case C-81/24 (Jenec) and protection against extraterritorial sanctions targeting international justice E-10-2026-002968Written questionwith 15 co-authors17 Sept 2026
14 Jul 2026State of play of negotiations on the agreement on the exchange of personal data between Europol and Israel E-10-2026-002925Written questionwith 24 co-authors1 Sept 2026
8 Jul 2026European funds allocated to fighting period poverty E-10-2026-002822Written questionwith 36 co-authorsNot yet answered
7 Jul 2026Transparency regarding EU-funded infrastructure destroyed in Gaza E-10-2026-002805Written questionwith 39 co-authors4 Sept 2026

Show all 132 questions and motions

Amendments tabled in committee, 57

Committee amendment documents that carry amendments by the member, with how many are theirs.

Show all 57 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Italy National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Cecilia STRADA”. Member record. memberId 257101. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257101?page=77&scope=final&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257101. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257101?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257101,
  author = {{EU Parl Watch Research}},
  title = {{Cecilia STRADA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257101?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/257101?page=77&scope=final&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257101. Official source: https://www.europarl.europa.eu/meps/en/257101. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}